Event dossier

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.

1 report1 sourceJun 3, 2026, 12:52 PM
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

CNBCJun 3, 2026, 12:52 PM

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.